PHILADELPHIA — Last May, an air monitor on the border of the East Coast’s largest oil refinery recorded a level of cancer-causing gas more than 21 times the federal limit. In June, an explosive early-morning fire rocked the Philadelphia Energy Solutions refinery, terrifying nearby residents. Weeks after the disaster, as PES filed for bankruptcy and …
They experienced the war in Afghanistan on the ground. Here’s what they had to say.
Three drugs are responsible for creating the deadly U.S. opioid epidemic: prescription pain pills, heroin and fentanyl. As of 2018, the crisis had claimed more than 400,000 lives. Yet the faces of some victims remain hidden. Grieving families embarrassed by the stigma of drug abuse write “passed peacefully at home” in obituaries. Recovering addicts meet …
How addiction starts
A dozen years ago, the federal government came down hard on Purdue Pharma, fining the drugmaker and three of its executives a record $634 million for misbranding its blockbuster OxyContin pill as safer and less addictive than other painkillers. In the decade leading up to the 2007 fine, Purdue helped change the culture of prescribing …
Scholars and experts are frequently called before Congress to testify, and sometimes do so without disclosing potential financial conflicts. A lack of accountability helps witnesses not disclose foreign funding as required, whether intentionally or not.
Walgreens dominated the nation’s retail opioid market from 2006 through 2012, buying about 13 billion pills — 3 billion more than its closest competitor.
Inside the plaintiffs’ war room, bleary-eyed, caffeinated lawyers worked on what would be one of the most important cases of their careers — the first bellwether trial in the national opioid litigation against the country’s biggest drug companies.
Demand for exotic pets and collectors’ items drives a flourishing illegal trade in beetles, spiders, and more.
Newly unsealed documents in a landmark civil case in Cleveland provide clues to one of the most enduring mysteries of the opioid epidemic: How were drug companies able to weaken the federal government’s most powerful enforcement weapon at the height of the crisis? The industry enlisted members of Congress to limit the powers of the …
Continue reading “Inside the drug industry’s plan to defeat the DEA”
Seeing a need to streamline public data sets, we built The Accountability Project to put much of that data in one place so journalists, researchers and others could search across otherwise siloed data.
Investigating Power is a history of breakthrough investigations that revealed news and changed the national narrative on many major topics since the 1950s, from war to health to civil rights.
An interactive timeline examines President Trump’s use of executive orders to restrict access to the U.S.
In April 2016, at the height of the deadliest drug epidemic in U.S. history, Congress effectively stripped the Drug Enforcement Administration of its most potent weapon against large drug companies suspected of spilling prescription narcotics onto the nation’s streets. A Washington Post investigation.
Investigative Reporting Workshop
4400 Massachusetts Ave. NW
Washington, D.C. 20016-8017